12:00 AM
 | 
Sep 06, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AAD-2004: Phase I started

Neurotech began a double-blind, placebo-controlled Phase I trial to evaluate AAD-2004 in 32 healthy volunteers.

Neurotech...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >